Zofran

Company
GlaxoSmithKline

Approval Status
Approved January 1999

Treatment for
Oncology

Possible similar drugs
Zofran

Areas
Cancer & Oncology

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.

Zofran_569 Drug Information

The Zofran_569 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top